Database Update: Pharmaceutical Drug Import to Russia (December 2016)
In 2016, Russia imported 493.1 bln RUB worth of ready-made pharmaceuticals (free circulation prices). The in-bulk imports amounted to 100.2 bln RUB. In monetary terms, the imports of ready-made products and in-bulk products have increased by 8.1% and 17.1%, respectively. In physical terms, the import of ready-made products has increased by 0.5%, while the in-bulk import has a bigger rise.
Despite the obvious seasonal spike, the dynamics were mediocre, with 8.6% for ready-made drugs and 15.3% for in-bulk products. However, the imports hit an all-time high – Russia imported 59.3 bln RUB worth of pharmaceuticals in December 2016.
In physical terms, the imports have amounted to 42.8 bln minimum dosage units (MDU) since 2017, with an 8% annual dynamics, which shows a growing demand for imported pharmaceuticals.
Over the year, the number of payments in rubles for both ready-made and in-bulk imports increased more significantly, unlike payments in other currencies. In 2016, 94.4% of the import was payed for in rubles, which is 2.1% higher than in 2015. At the same time, payments in euros have fallen by nearly the same number. Russia also started to pay in Asian currencies more, in particular in Japanese yenas and Chinese yuans.
Dynamics of import of pharmaceuticals, including homeopathic and seawater drugs, to Russia, free circulation prices including customs clearance, RUB (January 2015 – December 2016)